FIELD: chemistry.
SUBSTANCE: present invention relates to a method of producing a compound of formula I or pharmaceutically acceptable salt thereof, where R1 represents halogen or C1-6alkyl; and R2 represents hydrogen, which includes a step for reacting a compound of formula 2A, where R3 is hydrogen or C1-6alkyl with an acid to form a compound of formula I. Compound of formula 2A is obtained by reacting a compound of formula 3A with compound of formula 4A, where X1 is -Cl, -Br or triflyl group. Compound of formula 4A is obtained by reacting a compound of formula 5A with R3ONH2·HCl, where X1 is Cl or Br. Invention also relates to a specific compound of formula 2A, where R3 represents hydrogen or unsubstituted C1-6alkyl.
EFFECT: technical result is method of producing compounds reducing binding and activation of nuclear transcription factor PPARγ, scalable for industrial application.
17 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
THIAZOLIDINEDIONE ANALOGUES | 2007 |
|
RU2445957C2 |
PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
THIAZOLIDINEDIONE ANALOGUES FOR TREATING DIABETES AND DYSLIPIDEMIA | 2008 |
|
RU2486179C2 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
SERINE PROTEASE INHIBITORS | 2006 |
|
RU2441020C2 |
Authors
Dates
2016-08-20—Published
2011-08-09—Filed